Osterweis Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Osterweis Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-96,120	Closed	-$4.32M	–	228
2022 Q4	$4.32M	Sell	96,120 -1,670	-2%	-$75.6K	0.31%	84
2022 Q3	$4.68M	Sell	97,790 -31,910	-25%	-$1.75M	0.35%	74
2022 Q2	$7.68M	Buy	129,700 +47,860	+58%	+$3.93M	0.58%	52
2022 Q1	$9.52M	Sell	81,840 -19,840	-20%	-$2.32M	0.52%	63
2021 Q4	$15.3M	Buy	101,680 +15,995	+19%	+$2.16M	0.77%	46
2021 Q3	$10.2M	Sell	85,685 -38,500	-31%	-$4.24M	0.56%	59
2021 Q2	$12.1M	Buy	124,185 +23,005	+23%	+$2.05M	0.62%	55
2021 Q1	$8.93M	Buy	+101,180	New	+$9.4M	0.49%	62
2020 Q1	–	Sell	-65,665	Closed	-$3.91M	–	124
2019 Q4	$3.91M	Buy	65,665 +34,990	+114%	+$2.16M	0.27%	68
2019 Q3	$1.81M	Buy	+30,675	New	+$1.96M	0.13%	84

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Osterweis Capital Management's TNDM Position: Q1 2023 in Review

Osterweis Capital Management sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 96,120 shares — an estimated $4.32M sold.

Osterweis Capital Management first reported a position in TNDM in Q3 2019 and held it in 10 quarters. The position peaked at $15.3M in Q4 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

Osterweis Capital Management reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
Osterweis Capital Management sold 96,120 Tandem Diabetes Care shares in Q1 2023, an estimated $4.32M.
Osterweis Capital Management first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 10 quarters.
Osterweis Capital Management's Tandem Diabetes Care position peaked at $15.3M in Q4 2021.
273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Osterweis Capital Management's 13F filing for Q1 2023, filed 15 May 2023.